MAI Wealth Advisors »

Enanta Pharmaceuticals shares owned by MAI Wealth Advisors

Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by MAI Wealth Advisors from 13F filings

Historical chart of MAI Wealth Advisors investment in Enanta Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Enanta Pharmaceuticals held by MAI Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enanta Pharmaceuticals by MAI Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $110 7 15.86

More positions owned by MAI Wealth Advisors

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Call Call Option (Principal) (SPY)
Apple Call Call Option (Principal) (AAPL)
Microsoft Corp Call Call Option (Principal) (MSFT)
Ishares Tr Core S&p Mcp Etf (IJH)
Nvidia Corporation Call Call Option (Principal) (NVDA)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Alphabet Call Call Option (Principal) (GOOGL)
Amazon Call Call Option (Principal) (AMZN)
Invesco Qqq Tr Call Call Option (Principal) (QQQ)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr S&p 500 Val Etf (IVE)
Broadcom Call Call Option (Principal) (AVGO)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for MAI Wealth Advisors

Top funds holding Enanta Pharmaceuticals

BlackRock
Farallon Capital Management
Krensavage Asset Management
Vanguard Group
Deep Track Capital
Henderson Group
Millennium Management
Acadian Asset Management
Geode Capital Management
Renaissance Technologies
State Street Corporation
Point72 Asset Management
Hillsdale Investment Management
Marshall Wace
Invesco

View all funds holding Enanta Pharmaceuticals